flibanserin
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Brand name
- Trojanpharm
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- flibanserin, 147359-76-0, flibanserin hcl
- Category
- Pharmaceutical Intermediates
Guangzhou Trojan Pharmatech Ltd
China
- Verified Certificate
-
10
| Product name | flibanserin | Certification | - |
|---|---|---|---|
| Category | Pharmaceutical Intermediates | Ingredients | - |
| Keyword | flibanserin , 147359-76-0 , flibanserin hcl | Unit Size | - |
| Brand name | Trojanpharm | Unit Weigh | - |
| origin | China | Stock | - |
| Supply type | - | HS code | - |
Product Information
Flibanserin HCl
Product Name: Flibanserin Hydrochloride
Chemical Formula: C20H22ClF3N4O
Molecular Weight: 426.86
CAS: 147359-76-0
Character: white powder
Purity (HPLC): 99.0%
On June 4,
2015, the panel to the FDA recommended approval of the drug by 18–6. On August
18 2015, Flibanserin (Addyi) 100mg has been approved by the FDA.
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Mr. Zheng
- Address
- G11 Building, 31 Kefeng Road, South China New Materials Innovation Park , Science town, Guangzhou.
- Product Category
- Organic Intermediate
- Year Established
- 2013
- No. of Total Employees
- 51-100
- Company introduction
-
<p>
Based in China with global outreach, Guangzhou Trojan Pharmtech Ltd is a high-tech pharmaceutical enterprise covering the services of R&D, manufacturing, sales and export trading of APIs (Active Pharmaceutical Ingredient) and pharmaceutical intermediates. The company has also engaged in researching and developing new technologies for pharmaceutical preparations and new drug registration.
Headquartered in Guangzhou Science City, Trojan has set up a research center in International Business Incubator at South China Center for Innovative Pharmaceuticals with the support of Center’s platform of pharmaceutical services. Since the establishment in 2013, Trojan has made progress on a number of projects, some of which has been put into production and filed a Chinese invention patent. With the spirit of "working together to achieve perfection”, the company aims to become a leading domestic pharmaceutical enterprise with global competitiveness.
With its widespread use, the research and application of cordycepin is the future trend of pharmaceutical development. Since its establishment, Trojan Pharmtech has focus on the research and development of cordycepin. It has developed a set of advanced and unique biological and chemical synthesis technologies and achieved a high quality, low-cost industrial scale production of Cordyceps.
- Main Markets
-
India
Indonesia
Macao(China)
Malaysia
Pakistan
Philippines
- Main Product
